|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00137572
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.0013509
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.00122251
|
|
|
HPCX
|
[NCBI]
|
0.00112746
|
|
|
MSSD
|
[NCBI]
|
0.00103626
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.00103626
|
|
|
SRS
|
[NCBI]
|
0.000920202
|
|
|
CMD1K
|
[NCBI]
|
0.000771879
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.000771879
|
|
|
SLE
|
[NCBI]
|
0.000763847
|
|
|
dianzani autoimmune lymphoproliferative disease
|
[NCBI]
|
0.000672614
|
|
|
CF
|
[NCBI]
|
0.000624855
|
|
|
EXT3
|
[NCBI]
|
0.000608445
|
|
|
ARVD5
|
[NCBI]
|
0.000608445
|
|
|
ARVD3
|
[NCBI]
|
0.000608445
|
|
|
MCDU
|
[NCBI]
|
0.000608445
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
0.000608445
|
|
|
CMT2B2
|
[NCBI]
|
0.000608445
|
|
|
BRCA3
|
[NCBI]
|
0.000608445
|
|
|
ARVD4
|
[NCBI]
|
0.000608445
|
|
|
CHDM
|
[NCBI]
|
0.000608445
|
|
|
ETM2
|
[NCBI]
|
0.000560945
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.000560945
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.000523263
|
|
|
RP
|
[NCBI]
|
0.000496348
|
|
|
MSSE
|
[NCBI]
|
0.000492068
|
|
|
AUTS9
|
[NCBI]
|
0.000465483
|
|
|
ear, patella, short stature syndrome
|
[NCBI]
|
0.000465483
|
|
|
APC
|
[NCBI]
|
0.000447022
|
|
|
CDB2
|
[NCBI]
|
0.000442347
|
|
|
IDDM4
|
[NCBI]
|
0.000371866
|
|
|
DURS1
|
[NCBI]
|
0.000345139
|
|
|
EGF
|
[NCBI]
|
0.000320438
|
|
|
SHFM3
|
[NCBI]
|
0.000311673
|
|
|
TNF
|
[NCBI]
|
0.000305106
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000283919
|
|
|
PJS
|
[NCBI]
|
0.000246694
|
|
|
SCCMS
|
[NCBI]
|
0.000241274
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000227611
|
|
|
KCNQ1
|
[NCBI]
|
0.000226537
|
|
|
VEGF
|
[NCBI]
|
0.000224252
|
|
|
MFS
|
[NCBI]
|
0.000214009
|
|
|
HSCR1
|
[NCBI]
|
0.000213463
|
|
|
TCOF
|
[NCBI]
|
0.000204608
|
|
|
RTADR
|
[NCBI]
|
0.000199842
|
|
|
MAFD2
|
[NCBI]
|
0.000196112
|
|
|
SHFM1
|
[NCBI]
|
0.000182688
|
|
|
NF2
|
[NCBI]
|
0.000179676
|
|
|
CMH8
|
[NCBI]
|
0.000177833
|
|
|
WAS
|
[NCBI]
|
0.000174656
|
|
|
CACNA1A
|
[NCBI]
|
0.000173236
|
|
|
SCN5A
|
[NCBI]
|
0.000170543
|
|
|
MTM1
|
[NCBI]
|
0.000169903
|
|
|
leopard syndrome 1
|
[NCBI]
|
0.000168058
|
|
|
brugada syndrome 1
|
[NCBI]
|
0.000163413
|
|
|
LQT1
|
[NCBI]
|
0.000161589
|
|
|
PRL
|
[NCBI]
|
0.000161524
|
|
|
TS
|
[NCBI]
|
0.0001588
|
|
|
GLC1A
|
[NCBI]
|
0.000156143
|
|
|
CTNS
|
[NCBI]
|
0.000156143
|
|
|
AML
|
[NCBI]
|
0.000153439
|
|
|
NGFB
|
[NCBI]
|
0.000149635
|
|
|
glycogen storage disease iii
|
[NCBI]
|
0.000147364
|
|
|
BCNS
|
[NCBI]
|
0.000146136
|
|
|
CDB1
|
[NCBI]
|
0.000146063
|
|
|
CDKN2A
|
[NCBI]
|
0.000144587
|
|
|
MYOC
|
[NCBI]
|
0.000139629
|
|
|
MG
|
[NCBI]
|
0.000139012
|
|
|
PSACH
|
[NCBI]
|
0.000138718
|
|
|
pheochromocytoma
|
[NCBI]
|
0.000137347
|
|
|
VHL
|
[NCBI]
|
0.000136965
|
|
|
TSC1
|
[NCBI]
|
0.000133524
|
|
|
PPSH
|
[NCBI]
|
0.000131393
|
|
|
TSC2
|
[NCBI]
|
0.000129239
|
|
|
EDM1
|
[NCBI]
|
0.000128464
|
|
|
papillorenal syndrome
|
[NCBI]
|
0.000128464
|
|
|
RPS6KA3
|
[NCBI]
|
0.000125696
|
|
|
JLNS1
|
[NCBI]
|
0.000123664
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
0.000123664
|
|
|
wilson disease
|
[NCBI]
|
0.000123042
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
0.000122761
|
|
|
CHM
|
[NCBI]
|
0.000122625
|
|
|
CTNS
|
[NCBI]
|
0.000118067
|
|
|
KLK3
|
[NCBI]
|
0.0001168
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
0.000111397
|
|
|
ACHE
|
[NCBI]
|
0.000110578
|
|
|
LDLR
|
[NCBI]
|
0.000110391
|
|
|
aHUS
|
[NCBI]
|
0.000107651
|
|
|
NPY
|
[NCBI]
|
0.00010557
|
|
|
FGFR3
|
[NCBI]
|
0.000105213
|
|
|
PTH
|
[NCBI]
|
0.000104752
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
0.000102271
|
|
|
JAG1
|
[NCBI]
|
0.000101678
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
0.000101448
|
|
|
VHL
|
[NCBI]
|
0.00010133
|
|
|
GJB2
|
[NCBI]
|
0.000101183
|
|
|
PKD2
|
[NCBI]
|
0.000100332
|
|
|
BRCA1
|
[NCBI]
|
0.000100323
|
|
|
ATP7B
|
[NCBI]
|
9.95253e-05
|
|
|
TGFBI
|
[NCBI]
|
9.94168e-05
|
|
|
SMN1
|
[NCBI]
|
9.77372e-05
|
|
|
faciogenital dysplasia
|
[NCBI]
|
9.5741e-05
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
9.5741e-05
|
|
|
foveal hypoplasia and presenile cataract syndrome
|
[NCBI]
|
9.51196e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
9.42007e-05
|
|
|
CHRNE
|
[NCBI]
|
9.35729e-05
|
|
|
PTCH1
|
[NCBI]
|
9.35729e-05
|
|
|
SCA6
|
[NCBI]
|
9.34555e-05
|
|
|
PWS
|
[NCBI]
|
9.29396e-05
|
|
|
SGSH
|
[NCBI]
|
9.18381e-05
|
|
|
SLC4A1
|
[NCBI]
|
9.13329e-05
|
|
|
WAS
|
[NCBI]
|
9.10966e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
9.03149e-05
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
8.91309e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
8.91309e-05
|
|
|
hyaluronidase deficiency
|
[NCBI]
|
8.89048e-05
|
|
|
MCOPCB5
|
[NCBI]
|
8.89048e-05
|
|
|
ROCA
|
[NCBI]
|
8.89048e-05
|
|
|
ectopia pupillae
|
[NCBI]
|
8.89048e-05
|
|
|
NEM4
|
[NCBI]
|
8.89048e-05
|
|
|
RP30
|
[NCBI]
|
8.89048e-05
|
|
|
noncompaction of left ventricular myocardium with congenital heart defects
|
[NCBI]
|
8.89048e-05
|
|
|
CCM
|
[NCBI]
|
8.74281e-05
|
|
|
AN2
|
[NCBI]
|
8.74281e-05
|
|
|
CLS
|
[NCBI]
|
8.60122e-05
|
|
|
PMP22
|
[NCBI]
|
8.44216e-05
|
|
|
G6PT1
|
[NCBI]
|
8.41996e-05
|
|
|
fundus albipunctatus
|
[NCBI]
|
8.3986e-05
|
|
|
HFE3
|
[NCBI]
|
8.3986e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
8.3986e-05
|
|
|
FHM1
|
[NCBI]
|
8.37925e-05
|
|
|
GJB1
|
[NCBI]
|
8.33797e-05
|
|
|
NPC1
|
[NCBI]
|
8.06704e-05
|
|
|
EDNRB
|
[NCBI]
|
8.04372e-05
|
|
|
STGD1
|
[NCBI]
|
7.97248e-05
|
|
|
CSNB2A
|
[NCBI]
|
7.94824e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
7.94824e-05
|
|
|
apc gene
|
[NCBI]
|
7.93552e-05
|
|
|
RET
|
[NCBI]
|
7.90774e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
7.78328e-05
|
|
|
RP3
|
[NCBI]
|
7.78136e-05
|
|
|
FGD1
|
[NCBI]
|
7.77952e-05
|
|
|
AVP
|
[NCBI]
|
7.76942e-05
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
7.59768e-05
|
|
|
SRD5A2
|
[NCBI]
|
7.56113e-05
|
|
|
kniest dysplasia
|
[NCBI]
|
7.54828e-05
|
|
|
cystinuria
|
[NCBI]
|
7.42091e-05
|
|
|
L1CAM
|
[NCBI]
|
7.39075e-05
|
|
|
PAX6
|
[NCBI]
|
7.38751e-05
|
|
|
EYA1
|
[NCBI]
|
7.32487e-05
|
|
|
porphyria variegata
|
[NCBI]
|
7.23875e-05
|
|
|
CDA
|
[NCBI]
|
7.18901e-05
|
|
|
SFD
|
[NCBI]
|
7.18901e-05
|
|
|
CMT4A
|
[NCBI]
|
7.18901e-05
|
|
|
MTC
|
[NCBI]
|
7.18901e-05
|
|
|
MAT1A
|
[NCBI]
|
7.09747e-05
|
|
|
CASR
|
[NCBI]
|
6.97216e-05
|
|
|
MM
|
[NCBI]
|
6.92793e-05
|
|
|
NPC1
|
[NCBI]
|
6.90533e-05
|
|
|
ARH
|
[NCBI]
|
6.86327e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
6.86327e-05
|
|
|
GFAP
|
[NCBI]
|
6.81774e-05
|
|
|
FIH
|
[NCBI]
|
6.7748e-05
|
|
|
RPGR
|
[NCBI]
|
6.66604e-05
|
|
|
CYBB
|
[NCBI]
|
6.62793e-05
|
|
|
HGF
|
[NCBI]
|
6.59928e-05
|
|
|
EPO
|
[NCBI]
|
6.58309e-05
|
|
|
LQT3
|
[NCBI]
|
6.56565e-05
|
|
|
AIS
|
[NCBI]
|
6.3205e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
6.29195e-05
|
|
|
HPE3
|
[NCBI]
|
6.29195e-05
|
|
|
FSHMD1A
|
[NCBI]
|
6.28906e-05
|
|
|
GLC1G
|
[NCBI]
|
6.13691e-05
|
|
|
schizencephaly
|
[NCBI]
|
6.13691e-05
|
|
|
parkinson-dementia syndrome
|
[NCBI]
|
6.13691e-05
|
|
|
internal carotid artery, spontaneous dissection of
|
[NCBI]
|
6.13691e-05
|
|
|
ehlers-danlos syndrome, autosomal recessive, cardiac valvular form
|
[NCBI]
|
6.13691e-05
|
|
|
cardiomyopathy, dilated, with quadriceps myopathy
|
[NCBI]
|
6.13691e-05
|
|
|
CMH10
|
[NCBI]
|
6.13691e-05
|
|
|
pseudoacromegaly with severe insulin resistance
|
[NCBI]
|
6.13691e-05
|
|
|
DMAT
|
[NCBI]
|
6.13691e-05
|
|
|
brevican
|
[NCBI]
|
6.13691e-05
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
6.13691e-05
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
6.13691e-05
|
|
|
AT
|
[NCBI]
|
5.9932e-05
|
|
|
HMBS
|
[NCBI]
|
5.98866e-05
|
|
|
FTD
|
[NCBI]
|
5.96726e-05
|
|
|
ABCA4
|
[NCBI]
|
5.93363e-05
|
|
|
CLCN5
|
[NCBI]
|
5.90494e-05
|
|
|
FSCN2
|
[NCBI]
|
5.90168e-05
|
|
|
NS1
|
[NCBI]
|
5.80632e-05
|
|
|
RSMD1
|
[NCBI]
|
5.80369e-05
|
|
|
HPC1
|
[NCBI]
|
5.80369e-05
|
|
|
TCOF1
|
[NCBI]
|
5.685e-05
|
|
|
ALGS1
|
[NCBI]
|
5.59485e-05
|
|
|
EA2
|
[NCBI]
|
5.58427e-05
|
|
|
PD
|
[NCBI]
|
5.54629e-05
|
|
|
PKD1
|
[NCBI]
|
5.5051e-05
|
|
|
MPO
|
[NCBI]
|
5.40462e-05
|
|
|
IL2RG
|
[NCBI]
|
5.39138e-05
|
|
|
MTM1
|
[NCBI]
|
5.39138e-05
|
|
|
ESCS
|
[NCBI]
|
5.37878e-05
|
|
|
PEX1
|
[NCBI]
|
5.22708e-05
|
|
|
masa syndrome
|
[NCBI]
|
5.18572e-05
|
|
|
NF2
|
[NCBI]
|
5.16104e-05
|
|
|
adenosine triphosphate, elevated, of erythrocytes
|
[NCBI]
|
5.11242e-05
|
|
|
CMD1L
|
[NCBI]
|
5.11242e-05
|
|
|
EDM5
|
[NCBI]
|
5.11242e-05
|
|
|
slowed nerve conduction velocity, autosomal dominant
|
[NCBI]
|
5.11242e-05
|
|
|
fundus dystrophy, pseudoinflammatory, recessive form
|
[NCBI]
|
5.11242e-05
|
|
|
yemenite deaf-blind hypopigmentation syndrome
|
[NCBI]
|
5.11242e-05
|
|
|
chondrosarcoma
|
[NCBI]
|
5.11242e-05
|
|
|
otofaciocervical syndrome
|
[NCBI]
|
5.11242e-05
|
|
|
coats disease
|
[NCBI]
|
5.11242e-05
|
|
|
hypothyroidism, athyroidal, with spiky hair and cleft palate
|
[NCBI]
|
5.11242e-05
|
|
|
EDMD3
|
[NCBI]
|
5.11242e-05
|
|
|
MRX63
|
[NCBI]
|
5.11242e-05
|
|
|
advanced sleep-phase syndrome, familial
|
[NCBI]
|
5.11242e-05
|
|
|
basal cell carcinoma, multiple
|
[NCBI]
|
5.11242e-05
|
|
|
mandibulofacial dysostosis, treacher collins type, autosomal recessive
|
[NCBI]
|
5.11242e-05
|
|
|
glycogen storage disease 0, liver
|
[NCBI]
|
5.11242e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
5.11242e-05
|
|
|
blood group--froese
|
[NCBI]
|
5.11242e-05
|
|
|
RP26
|
[NCBI]
|
5.11242e-05
|
|
|
HHF2
|
[NCBI]
|
5.05955e-05
|
|
|
MPZ
|
[NCBI]
|
5.05346e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
5.00381e-05
|
|
|
RHO
|
[NCBI]
|
4.96693e-05
|
|
|
TH
|
[NCBI]
|
4.94172e-05
|
|
|
CDH1
|
[NCBI]
|
4.92899e-05
|
|
|
CEACAM5
|
[NCBI]
|
4.90657e-05
|
|
|
PPEF1
|
[NCBI]
|
4.88833e-05
|
|
|
MBP
|
[NCBI]
|
4.86997e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
4.83195e-05
|
|
|
PPOX
|
[NCBI]
|
4.6925e-05
|
|
|
coproporphyria
|
[NCBI]
|
4.56389e-05
|
|
|
HOKPP
|
[NCBI]
|
4.51478e-05
|
|
|
AGL
|
[NCBI]
|
4.48699e-05
|
|
|
MYBPC3
|
[NCBI]
|
4.48699e-05
|
|
|
FBN1
|
[NCBI]
|
4.46144e-05
|
|
|
HPE5
|
[NCBI]
|
4.45546e-05
|
|
|
melanoma-astrocytoma syndrome
|
[NCBI]
|
4.45546e-05
|
|
|
ARMD2
|
[NCBI]
|
4.45546e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
4.45546e-05
|
|
|
erythrocyte lactate transporter defect
|
[NCBI]
|
4.45546e-05
|
|
|
CMM3
|
[NCBI]
|
4.45546e-05
|
|
|
EBN2
|
[NCBI]
|
4.45546e-05
|
|
|
SPG20
|
[NCBI]
|
4.45546e-05
|
|
|
CMD1C
|
[NCBI]
|
4.45546e-05
|
|
|
SW
|
[NCBI]
|
4.45546e-05
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
4.45546e-05
|
|
|
MRT2
|
[NCBI]
|
4.45546e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
4.45546e-05
|
|
|
segawa syndrome, autosomal recessive
|
[NCBI]
|
4.45546e-05
|
|
|
proprotein convertase 1 deficiency
|
[NCBI]
|
4.45546e-05
|
|
|
OPTN
|
[NCBI]
|
4.44266e-05
|
|
|
KCNH2
|
[NCBI]
|
4.37329e-05
|
|
|
THBD
|
[NCBI]
|
4.37134e-05
|
|
|
ELAC2
|
[NCBI]
|
4.37134e-05
|
|
|
PBD
|
[NCBI]
|
4.36794e-05
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
4.36794e-05
|
|
|
NEM3
|
[NCBI]
|
4.36794e-05
|
|
|
CFH
|
[NCBI]
|
4.24532e-05
|
|
|
RYR1
|
[NCBI]
|
4.2453e-05
|
|
|
LCA1
|
[NCBI]
|
4.22807e-05
|
|
|
GIST
|
[NCBI]
|
4.17788e-05
|
|
|
GLRA1
|
[NCBI]
|
4.1617e-05
|
|
|
TTR
|
[NCBI]
|
4.12784e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
4.09464e-05
|
|
|
PMP2
|
[NCBI]
|
4.02995e-05
|
|
|
PPP2R1B
|
[NCBI]
|
4.02995e-05
|
|
|
AMHR2
|
[NCBI]
|
4.02995e-05
|
|
|
SVAS
|
[NCBI]
|
4.01579e-05
|
|
|
TD1
|
[NCBI]
|
4.01579e-05
|
|
|
BDNF
|
[NCBI]
|
4.00991e-05
|
|
|
insulin-like growth factor i deficiency
|
[NCBI]
|
3.97306e-05
|
|
|
PCWH
|
[NCBI]
|
3.97306e-05
|
|
|
RCD3A
|
[NCBI]
|
3.97306e-05
|
|
|
pseudohypoaldosteronism, type i, autosomal dominant
|
[NCBI]
|
3.97306e-05
|
|
|
EDM2
|
[NCBI]
|
3.97306e-05
|
|
|
IDDM12
|
[NCBI]
|
3.97306e-05
|
|
|
DFNA10
|
[NCBI]
|
3.97306e-05
|
|
|
DFNA13
|
[NCBI]
|
3.97306e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
3.97306e-05
|
|
|
watson syndrome
|
[NCBI]
|
3.97306e-05
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
3.97306e-05
|
|
|
LVNC1
|
[NCBI]
|
3.97306e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
3.97306e-05
|
|
|
RP15
|
[NCBI]
|
3.97306e-05
|
|
|
weyers acrofacial dysostosis
|
[NCBI]
|
3.97306e-05
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
3.97306e-05
|
|
|
VF
|
[NCBI]
|
3.97306e-05
|
|
|
pseudodiastrophic dysplasia
|
[NCBI]
|
3.97306e-05
|
|
|
HCHOLA3
|
[NCBI]
|
3.97306e-05
|
|
|
LCA2
|
[NCBI]
|
3.97306e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
3.97306e-05
|
|
|
CDHS
|
[NCBI]
|
3.97306e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
3.97306e-05
|
|
|
neural tube defects
|
[NCBI]
|
3.96714e-05
|
|
|
BOR1
|
[NCBI]
|
3.96714e-05
|
|
|
TDG
|
[NCBI]
|
3.89005e-05
|
|
|
BTK
|
[NCBI]
|
3.82741e-05
|
|
|
HSD17B3
|
[NCBI]
|
3.76362e-05
|
|
|
MYL3
|
[NCBI]
|
3.76362e-05
|
|
|
PTGIS
|
[NCBI]
|
3.76362e-05
|
|
|
NDST1
|
[NCBI]
|
3.76362e-05
|
|
|
CYP1B1
|
[NCBI]
|
3.73119e-05
|
|
|
HHC1
|
[NCBI]
|
3.72828e-05
|
|
|
CCK
|
[NCBI]
|
3.68591e-05
|
|
|
NF1
|
[NCBI]
|
3.62906e-05
|
|
|
OTC
|
[NCBI]
|
3.62646e-05
|
|
|
MYH7
|
[NCBI]
|
3.62646e-05
|
|
|
STHAG1
|
[NCBI]
|
3.59348e-05
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
3.59348e-05
|
|
|
amyloidosis vii
|
[NCBI]
|
3.59348e-05
|
|
|
DFNB18
|
[NCBI]
|
3.59348e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
3.59348e-05
|
|
|
HPE4
|
[NCBI]
|
3.59348e-05
|
|
|
OCA4
|
[NCBI]
|
3.59348e-05
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
3.59348e-05
|
|
|
peters anomaly
|
[NCBI]
|
3.59348e-05
|
|
|
thrombophilia
|
[NCBI]
|
3.59348e-05
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
3.59348e-05
|
|
|
oguchi disease
|
[NCBI]
|
3.59348e-05
|
|
|
EVR4
|
[NCBI]
|
3.59348e-05
|
|
|
ARVD2
|
[NCBI]
|
3.59348e-05
|
|
|
SHFM4
|
[NCBI]
|
3.59348e-05
|
|
|
RP17
|
[NCBI]
|
3.59348e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2j
|
[NCBI]
|
3.59348e-05
|
|
|
DFNA11
|
[NCBI]
|
3.59348e-05
|
|
|
SLC3A1
|
[NCBI]
|
3.58656e-05
|
|
|
PSEN2
|
[NCBI]
|
3.54898e-05
|
|
|
COMP
|
[NCBI]
|
3.53742e-05
|
|
|
PAX2
|
[NCBI]
|
3.51886e-05
|
|
|
EXT1
|
[NCBI]
|
3.51886e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
3.50856e-05
|
|
|
MODY
|
[NCBI]
|
3.42871e-05
|
|
|
costello syndrome
|
[NCBI]
|
3.4051e-05
|
|
|
LGMD2A
|
[NCBI]
|
3.4051e-05
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
3.39151e-05
|
|
|
CUL2
|
[NCBI]
|
3.36687e-05
|
|
|
DTNA
|
[NCBI]
|
3.36687e-05
|
|
|
SPG4
|
[NCBI]
|
3.30556e-05
|
|
|
RP9
|
[NCBI]
|
3.28182e-05
|
|
|
LGMD1C
|
[NCBI]
|
3.28182e-05
|
|
|
FMO2
|
[NCBI]
|
3.28182e-05
|
|
|
KNO
|
[NCBI]
|
3.28182e-05
|
|
|
STHAG3
|
[NCBI]
|
3.28182e-05
|
|
|
HNSCC
|
[NCBI]
|
3.28182e-05
|
|
|
AOII
|
[NCBI]
|
3.28182e-05
|
|
|
amme complex
|
[NCBI]
|
3.28182e-05
|
|
|
CORD3
|
[NCBI]
|
3.28182e-05
|
|
|
EAD
|
[NCBI]
|
3.28182e-05
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
3.28182e-05
|
|
|
LGMD2J
|
[NCBI]
|
3.28182e-05
|
|
|
BIRC1
|
[NCBI]
|
3.26657e-05
|
|
|
CD40LG
|
[NCBI]
|
3.21789e-05
|
|
|
GCDH
|
[NCBI]
|
3.21789e-05
|
|
|
CCD
|
[NCBI]
|
3.21347e-05
|
|
|
COL9A2
|
[NCBI]
|
3.21081e-05
|
|
|
TDGF1
|
[NCBI]
|
3.21081e-05
|
|
|
GRHPR
|
[NCBI]
|
3.21081e-05
|
|
|
OCA2
|
[NCBI]
|
3.20971e-05
|
|
|
EGFR
|
[NCBI]
|
3.19802e-05
|
|
|
CAPN3
|
[NCBI]
|
3.16405e-05
|
|
|
COL1A1
|
[NCBI]
|
3.14502e-05
|
|
|
OPA1
|
[NCBI]
|
3.11733e-05
|
|
|
GCPS
|
[NCBI]
|
3.11733e-05
|
|
|
COL10A1
|
[NCBI]
|
3.11201e-05
|
|
|
DYSF
|
[NCBI]
|
3.11201e-05
|
|
|
RP1
|
[NCBI]
|
3.07379e-05
|
|
|
ING1
|
[NCBI]
|
3.07379e-05
|
|
|
CLCN1
|
[NCBI]
|
3.06167e-05
|
|
|
ATS
|
[NCBI]
|
3.02822e-05
|
|
|
OPLL
|
[NCBI]
|
3.01845e-05
|
|
|
mast cell disease
|
[NCBI]
|
3.01845e-05
|
|
|
PGL4
|
[NCBI]
|
3.01845e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
3.01845e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
3.01845e-05
|
|
|
CMT4B1
|
[NCBI]
|
3.01845e-05
|
|
|
CPNE7
|
[NCBI]
|
3.01011e-05
|
|
|
UNC93A
|
[NCBI]
|
3.01011e-05
|
|
|
RP1L1
|
[NCBI]
|
3.01011e-05
|
|
|
C7ORF28
|
[NCBI]
|
3.01011e-05
|
|
|
HPS6
|
[NCBI]
|
3.01011e-05
|
|
|
GALNT8
|
[NCBI]
|
3.01011e-05
|
|
|
KIF20A
|
[NCBI]
|
3.01011e-05
|
|
|
REXO4
|
[NCBI]
|
3.01011e-05
|
|
|
SPATA4
|
[NCBI]
|
3.01011e-05
|
|
|
FAM53C
|
[NCBI]
|
3.01011e-05
|
|
|
CDK4
|
[NCBI]
|
2.96107e-05
|
|
|
T
|
[NCBI]
|
2.95175e-05
|
|
|
SGCG
|
[NCBI]
|
2.95175e-05
|
|
|
CGD
|
[NCBI]
|
2.93151e-05
|
|
|
BCL6
|
[NCBI]
|
2.91985e-05
|
|
|
FANCA
|
[NCBI]
|
2.87536e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
2.87536e-05
|
|
|
HHF1
|
[NCBI]
|
2.85913e-05
|
|
|
SLC7A9
|
[NCBI]
|
2.84178e-05
|
|
|
osteogenic sarcoma
|
[NCBI]
|
2.79118e-05
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
2.79118e-05
|
|
|
GGM
|
[NCBI]
|
2.79118e-05
|
|
|
DFNA3
|
[NCBI]
|
2.79118e-05
|
|
|
RP12
|
[NCBI]
|
2.79118e-05
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
2.79118e-05
|
|
|
DFNA9
|
[NCBI]
|
2.79118e-05
|
|
|
CMH4
|
[NCBI]
|
2.79118e-05
|
|
|
ADHR
|
[NCBI]
|
2.79118e-05
|
|
|
OCA3
|
[NCBI]
|
2.79118e-05
|
|
|
SPG11
|
[NCBI]
|
2.79118e-05
|
|
|
NSHPT
|
[NCBI]
|
2.79118e-05
|
|
|
PKLR
|
[NCBI]
|
2.79015e-05
|
|
|
HPS
|
[NCBI]
|
2.78162e-05
|
|
|
PCNA
|
[NCBI]
|
2.76606e-05
|
|
|
STK11
|
[NCBI]
|
2.74929e-05
|
|
|
MATN3
|
[NCBI]
|
2.74177e-05
|
|
|
SGCD
|
[NCBI]
|
2.74177e-05
|
|
|
SOD1
|
[NCBI]
|
2.65746e-05
|
|
|
NCF2
|
[NCBI]
|
2.65011e-05
|
|
|
HGD
|
[NCBI]
|
2.65011e-05
|
|
|
KCNJ1
|
[NCBI]
|
2.65011e-05
|
|
|
TSD
|
[NCBI]
|
2.63416e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
2.626e-05
|
|
|
TP53
|
[NCBI]
|
2.61231e-05
|
|
|
schwannomatosis
|
[NCBI]
|
2.59193e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
2.59193e-05
|
|
|
LISX1
|
[NCBI]
|
2.59193e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
2.59193e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
2.59193e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
2.59193e-05
|
|
|
HFE4
|
[NCBI]
|
2.59193e-05
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
2.59193e-05
|
|
|
FOLR1
|
[NCBI]
|
2.56555e-05
|
|
|
CACNA1F
|
[NCBI]
|
2.56555e-05
|
|
|
AGXT
|
[NCBI]
|
2.56555e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.56399e-05
|
|
|
HEXA
|
[NCBI]
|
2.56399e-05
|
|
|
VMD
|
[NCBI]
|
2.55323e-05
|
|
|
LI1
|
[NCBI]
|
2.55323e-05
|
|
|
GCK
|
[NCBI]
|
2.49813e-05
|
|
|
MEN1
|
[NCBI]
|
2.49813e-05
|
|
|
KCNQ2
|
[NCBI]
|
2.48711e-05
|
|
|
TAP1
|
[NCBI]
|
2.48711e-05
|
|
|
SLC26A3
|
[NCBI]
|
2.48711e-05
|
|
|
AFP
|
[NCBI]
|
2.45611e-05
|
|
|
COL3A1
|
[NCBI]
|
2.42504e-05
|
|
|
IRID1
|
[NCBI]
|
2.41507e-05
|
|
|
BOS1
|
[NCBI]
|
2.41507e-05
|
|
|
LGMD1A
|
[NCBI]
|
2.41507e-05
|
|
|
IRID2
|
[NCBI]
|
2.41507e-05
|
|
|
CDL1
|
[NCBI]
|
2.41507e-05
|
|
|
DYT1
|
[NCBI]
|
2.4144e-05
|
|
|
LRAT
|
[NCBI]
|
2.414e-05
|
|
|
LAMA2
|
[NCBI]
|
2.414e-05
|
|
|
RP2
|
[NCBI]
|
2.39312e-05
|
|
|
USH2A
|
[NCBI]
|
2.34556e-05
|
|
|
FXN
|
[NCBI]
|
2.30144e-05
|
|
|
FGFR2
|
[NCBI]
|
2.30002e-05
|
|
|
FOXC1
|
[NCBI]
|
2.28126e-05
|
|
|
USH1C
|
[NCBI]
|
2.28126e-05
|
|
|
DHFR
|
[NCBI]
|
2.2761e-05
|
|
|
LHCGR
|
[NCBI]
|
2.27216e-05
|
|
|
CD
|
[NCBI]
|
2.26637e-05
|
|
|
PSEN1
|
[NCBI]
|
2.2576e-05
|
|
|
DFNA6
|
[NCBI]
|
2.25651e-05
|
|
|
THC1
|
[NCBI]
|
2.25651e-05
|
|
|
SACS
|
[NCBI]
|
2.25651e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
2.25651e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
2.25651e-05
|
|
|
HHS
|
[NCBI]
|
2.25651e-05
|
|
|
SMA4
|
[NCBI]
|
2.25651e-05
|
|
|
SEDT
|
[NCBI]
|
2.25651e-05
|
|
|
LIS1
|
[NCBI]
|
2.25651e-05
|
|
|
PMDS
|
[NCBI]
|
2.25651e-05
|
|
|
medulloblastoma
|
[NCBI]
|
2.25651e-05
|
|
|
XPF
|
[NCBI]
|
2.25651e-05
|
|
|
galactosemia
|
[NCBI]
|
2.22148e-05
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
2.22148e-05
|
|
|
ACTC1
|
[NCBI]
|
2.22065e-05
|
|
|
FOXL2
|
[NCBI]
|
2.22065e-05
|
|
|
XRCC9
|
[NCBI]
|
2.22065e-05
|
|
|
HADHA
|
[NCBI]
|
2.22065e-05
|
|
|
GUCY2D
|
[NCBI]
|
2.22065e-05
|
|
|
KCNE1
|
[NCBI]
|
2.22065e-05
|
|
|
KRIT1
|
[NCBI]
|
2.22065e-05
|
|
|
PLP1
|
[NCBI]
|
2.21539e-05
|
|
|
MPP4
|
[NCBI]
|
2.18914e-05
|
|
|
LOH11CR2A
|
[NCBI]
|
2.18914e-05
|
|
|
ZNF214
|
[NCBI]
|
2.18914e-05
|
|
|
UBIAD1
|
[NCBI]
|
2.18914e-05
|
|
|
dynein, axonemal, intermediate chain 2
|
[NCBI]
|
2.18914e-05
|
|
|
PTPN23
|
[NCBI]
|
2.18914e-05
|
|
|
GPR19
|
[NCBI]
|
2.18914e-05
|
|
|
C5ORF5
|
[NCBI]
|
2.18914e-05
|
|
|
JMJD1B
|
[NCBI]
|
2.18914e-05
|
|
|
DLEC1
|
[NCBI]
|
2.18914e-05
|
|
|
DLEU2
|
[NCBI]
|
2.18914e-05
|
|
|
BBS7
|
[NCBI]
|
2.18914e-05
|
|
|
TOR2A
|
[NCBI]
|
2.18914e-05
|
|
|
ataxin 2-binding protein 1
|
[NCBI]
|
2.18914e-05
|
|
|
ZNF215
|
[NCBI]
|
2.18914e-05
|
|
|
DEC1
|
[NCBI]
|
2.18914e-05
|
|
|
SERF1A
|
[NCBI]
|
2.18914e-05
|
|
|
FBXL13
|
[NCBI]
|
2.18914e-05
|
|
|
DIRC1
|
[NCBI]
|
2.18914e-05
|
|
|
PTCH2
|
[NCBI]
|
2.18914e-05
|
|
|
DLEU1
|
[NCBI]
|
2.18914e-05
|
|
|
TOR1B
|
[NCBI]
|
2.18914e-05
|
|
|
DHCR7
|
[NCBI]
|
2.16335e-05
|
|
|
C9
|
[NCBI]
|
2.16335e-05
|
|
|
SMAD2
|
[NCBI]
|
2.16335e-05
|
|
|
obesity
|
[NCBI]
|
2.16092e-05
|
|
|
down syndrome
|
[NCBI]
|
2.16092e-05
|
|
|
APRT
|
[NCBI]
|
2.12676e-05
|
|
|
APOE
|
[NCBI]
|
2.12367e-05
|
|
|
CDGG1
|
[NCBI]
|
2.11318e-05
|
|
|
CMD3B
|
[NCBI]
|
2.11318e-05
|
|
|
MCDS
|
[NCBI]
|
2.11318e-05
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
2.11318e-05
|
|
|
crouzon syndrome
|
[NCBI]
|
2.11318e-05
|
|
|
septooptic dysplasia
|
[NCBI]
|
2.11318e-05
|
|
|
NCIE1
|
[NCBI]
|
2.11318e-05
|
|
|
CHRNA1
|
[NCBI]
|
2.10903e-05
|
|
|
DCX
|
[NCBI]
|
2.10903e-05
|
|
|
MHS1
|
[NCBI]
|
2.10209e-05
|
|
|
DKC1
|
[NCBI]
|
2.05742e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.03258e-05
|
|
|
ALPS
|
[NCBI]
|
2.02736e-05
|
|
|
UBE3A
|
[NCBI]
|
2.00828e-05
|
|
|
WFS1
|
[NCBI]
|
2.00828e-05
|
|
|
ATM
|
[NCBI]
|
1.9993e-05
|
|
|
SPD1
|
[NCBI]
|
1.98274e-05
|
|
|
NFNS
|
[NCBI]
|
1.98274e-05
|
|
|
ARVD1
|
[NCBI]
|
1.98274e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
1.98274e-05
|
|
|
STGD3
|
[NCBI]
|
1.98274e-05
|
|
|
LGMD1B
|
[NCBI]
|
1.98274e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
1.98274e-05
|
|
|
HSCR2
|
[NCBI]
|
1.98274e-05
|
|
|
PMM2
|
[NCBI]
|
1.9614e-05
|
|
|
EDA
|
[NCBI]
|
1.9614e-05
|
|
|
PPARA
|
[NCBI]
|
1.96031e-05
|
|
|
GCCR
|
[NCBI]
|
1.93945e-05
|
|
|
RCC1
|
[NCBI]
|
1.93537e-05
|
|
|
CTNNB1
|
[NCBI]
|
1.91699e-05
|
|
|
TGM1
|
[NCBI]
|
1.91658e-05
|
|
|
G6PD
|
[NCBI]
|
1.89221e-05
|
|
|
DIRAS3
|
[NCBI]
|
1.88162e-05
|
|
|
KIR2DS4
|
[NCBI]
|
1.88162e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.88162e-05
|
|
|
ARHGEF10
|
[NCBI]
|
1.88162e-05
|
|
|
TRAM2
|
[NCBI]
|
1.88162e-05
|
|
|
TMEM1
|
[NCBI]
|
1.88162e-05
|
|
|
MTTV
|
[NCBI]
|
1.88162e-05
|
|
|
CERKL
|
[NCBI]
|
1.88162e-05
|
|
|
HPS5
|
[NCBI]
|
1.88162e-05
|
|
|
BARX2
|
[NCBI]
|
1.88162e-05
|
|
|
TAF9
|
[NCBI]
|
1.88162e-05
|
|
|
MCM3
|
[NCBI]
|
1.88162e-05
|
|
|
COPG2
|
[NCBI]
|
1.88162e-05
|
|
|
DNAI1
|
[NCBI]
|
1.88162e-05
|
|
|
PDE6H
|
[NCBI]
|
1.88162e-05
|
|
|
MPST
|
[NCBI]
|
1.88162e-05
|
|
|
MYO9A
|
[NCBI]
|
1.88162e-05
|
|
|
EPB41L3
|
[NCBI]
|
1.88162e-05
|
|
|
SH3BP2
|
[NCBI]
|
1.88162e-05
|
|
|
MOBP
|
[NCBI]
|
1.88162e-05
|
|
|
ZNF239
|
[NCBI]
|
1.88162e-05
|
|
|
PWP2H
|
[NCBI]
|
1.88162e-05
|
|
|
WDR36
|
[NCBI]
|
1.88162e-05
|
|
|
MTTS2
|
[NCBI]
|
1.88162e-05
|
|
|
CRBN
|
[NCBI]
|
1.88162e-05
|
|
|
HYAL3
|
[NCBI]
|
1.88162e-05
|
|
|
TRPC5
|
[NCBI]
|
1.88162e-05
|
|
|
ABCD1
|
[NCBI]
|
1.87318e-05
|
|
|
SHBG
|
[NCBI]
|
1.86519e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
1.86334e-05
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
1.86334e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
1.86334e-05
|
|
|
JH
|
[NCBI]
|
1.86334e-05
|
|
|
PPCD1
|
[NCBI]
|
1.86334e-05
|
|
|
OPA1
|
[NCBI]
|
1.83253e-05
|
|
|
MC4R
|
[NCBI]
|
1.83081e-05
|
|
|
FSHR
|
[NCBI]
|
1.81014e-05
|
|
|
TIMP3
|
[NCBI]
|
1.79303e-05
|
|
|
DYT1
|
[NCBI]
|
1.79303e-05
|
|
|
BPES
|
[NCBI]
|
1.78202e-05
|
|
|
PITX2
|
[NCBI]
|
1.75504e-05
|
|
|
ARSB
|
[NCBI]
|
1.75504e-05
|
|
|
KRT14
|
[NCBI]
|
1.75504e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
1.7535e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
1.7535e-05
|
|
|
PFIC1
|
[NCBI]
|
1.7535e-05
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
1.7535e-05
|
|
|
HSAN2
|
[NCBI]
|
1.7535e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
1.7535e-05
|
|
|
coumarin resistance
|
[NCBI]
|
1.7535e-05
|
|
|
MLH1
|
[NCBI]
|
1.75008e-05
|
|
|
NOS2A
|
[NCBI]
|
1.71847e-05
|
|
|
HOS
|
[NCBI]
|
1.6865e-05
|
|
|
PPP5C
|
[NCBI]
|
1.68325e-05
|
|
|
EXTL1
|
[NCBI]
|
1.68325e-05
|
|
|
MAT2A
|
[NCBI]
|
1.68325e-05
|
|
|
CYP4F12
|
[NCBI]
|
1.68325e-05
|
|
|
ARHGAP8
|
[NCBI]
|
1.68325e-05
|
|
|
PIK3CB
|
[NCBI]
|
1.68325e-05
|
|
|
RBM6
|
[NCBI]
|
1.68325e-05
|
|
|
OXSR1
|
[NCBI]
|
1.68325e-05
|
|
|
CDX1
|
[NCBI]
|
1.68325e-05
|
|
|
FAIM2
|
[NCBI]
|
1.68325e-05
|
|
|
HPS4
|
[NCBI]
|
1.68325e-05
|
|
|
RP9
|
[NCBI]
|
1.68325e-05
|
|
|
PPT2
|
[NCBI]
|
1.68325e-05
|
|
|
GYS2
|
[NCBI]
|
1.68325e-05
|
|
|
PDE6D
|
[NCBI]
|
1.68325e-05
|
|
|
NEF3
|
[NCBI]
|
1.68325e-05
|
|
|
ING3
|
[NCBI]
|
1.68325e-05
|
|
|
ES1
|
[NCBI]
|
1.68325e-05
|
|
|
DUSP3
|
[NCBI]
|
1.68325e-05
|
|
|
MFAP1
|
[NCBI]
|
1.68325e-05
|
|
|
CLDN7
|
[NCBI]
|
1.68325e-05
|
|
|
FRG1
|
[NCBI]
|
1.68325e-05
|
|
|
COL4A5
|
[NCBI]
|
1.68323e-05
|
|
|
GPC3
|
[NCBI]
|
1.68323e-05
|
|
|
KCNJ11
|
[NCBI]
|
1.68323e-05
|
|
|
CSTB
|
[NCBI]
|
1.68323e-05
|
|
|
EDN3
|
[NCBI]
|
1.68323e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
1.65969e-05
|
|
|
OPTB3
|
[NCBI]
|
1.65202e-05
|
|
|
CORD2
|
[NCBI]
|
1.65202e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
1.65202e-05
|
|
|
DHRD
|
[NCBI]
|
1.65202e-05
|
|
|
alkaptonuria
|
[NCBI]
|
1.65202e-05
|
|
|
EEC3
|
[NCBI]
|
1.65202e-05
|
|
|
AHDS
|
[NCBI]
|
1.65202e-05
|
|
|
acromegaly
|
[NCBI]
|
1.65202e-05
|
|
|
PTPN11
|
[NCBI]
|
1.64923e-05
|
|
|
GLI3
|
[NCBI]
|
1.64923e-05
|
|
|
GCH1
|
[NCBI]
|
1.64923e-05
|
|
|
oca2 gene
|
[NCBI]
|
1.61638e-05
|
|
|
EV
|
[NCBI]
|
1.61522e-05
|
|
|
prostate cancer
|
[NCBI]
|
1.59593e-05
|
|
|
PAFAH1B1
|
[NCBI]
|
1.58464e-05
|
|
|
SOX10
|
[NCBI]
|
1.58464e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
1.55792e-05
|
|
|
SHEP2
|
[NCBI]
|
1.55792e-05
|
|
|
SPG4
|
[NCBI]
|
1.55392e-05
|
|
|
GAPDH
|
[NCBI]
|
1.55297e-05
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
1.53671e-05
|
|
|
PRDX3
|
[NCBI]
|
1.53671e-05
|
|
|
INTS6
|
[NCBI]
|
1.53671e-05
|
|
|
GPR44
|
[NCBI]
|
1.53671e-05
|
|
|
ADRA2B
|
[NCBI]
|
1.53671e-05
|
|
|
b-cell rag-associated gene
|
[NCBI]
|
1.53671e-05
|
|
|
MALL
|
[NCBI]
|
1.53671e-05
|
|
|
HYAL1
|
[NCBI]
|
1.53671e-05
|
|
|
DBC1
|
[NCBI]
|
1.53671e-05
|
|
|
LTBP3
|
[NCBI]
|
1.53671e-05
|
|
|
RAD54L
|
[NCBI]
|
1.53671e-05
|
|
|
KIR2DS2
|
[NCBI]
|
1.53671e-05
|
|
|
EFEMP1
|
[NCBI]
|
1.53671e-05
|
|
|
EVC
|
[NCBI]
|
1.53671e-05
|
|
|
SPG20
|
[NCBI]
|
1.53671e-05
|
|
|
RBM5
|
[NCBI]
|
1.53671e-05
|
|
|
GLRB
|
[NCBI]
|
1.53671e-05
|
|
|
GFRA3
|
[NCBI]
|
1.53671e-05
|
|
|
SHOX2
|
[NCBI]
|
1.53671e-05
|
|
|
KIR3DL2
|
[NCBI]
|
1.53671e-05
|
|
|
LEFTY1
|
[NCBI]
|
1.53671e-05
|
|
|
NINJ1
|
[NCBI]
|
1.53671e-05
|
|
|
FBP1
|
[NCBI]
|
1.53671e-05
|
|
|
TYRP1
|
[NCBI]
|
1.52418e-05
|
|
|
MJD
|
[NCBI]
|
1.50509e-05
|
|
|
PHEX
|
[NCBI]
|
1.49536e-05
|
|
|
NDP
|
[NCBI]
|
1.49536e-05
|
|
|
AVPR2
|
[NCBI]
|
1.49536e-05
|
|
|
MYO7A
|
[NCBI]
|
1.49536e-05
|
|
|
PTHR1
|
[NCBI]
|
1.49536e-05
|
|
|
PRPH2
|
[NCBI]
|
1.49536e-05
|
|
|
LEP
|
[NCBI]
|
1.49305e-05
|
|
|
COL1A2
|
[NCBI]
|
1.48724e-05
|
|
|
RB1
|
[NCBI]
|
1.47479e-05
|
|
|
HRPT1
|
[NCBI]
|
1.47039e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
1.47039e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
1.47039e-05
|
|
|
AIED
|
[NCBI]
|
1.47039e-05
|
|
|
IBM2
|
[NCBI]
|
1.47039e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
1.47039e-05
|
|
|
NPHP1
|
[NCBI]
|
1.47039e-05
|
|
|
ATP7A
|
[NCBI]
|
1.4674e-05
|
|
|
AR
|
[NCBI]
|
1.44642e-05
|
|
|
SHOX
|
[NCBI]
|
1.44027e-05
|
|
|
TPI1
|
[NCBI]
|
1.44027e-05
|
|
|
BBS
|
[NCBI]
|
1.43737e-05
|
|
|
ND
|
[NCBI]
|
1.4283e-05
|
|
|
MFRP
|
[NCBI]
|
1.42071e-05
|
|
|
SYNJ1
|
[NCBI]
|
1.42071e-05
|
|
|
VSX1
|
[NCBI]
|
1.42071e-05
|
|
|
EHD1
|
[NCBI]
|
1.42071e-05
|
|
|
CFC1
|
[NCBI]
|
1.42071e-05
|
|
|
RFXANK
|
[NCBI]
|
1.42071e-05
|
|
|
MYL2
|
[NCBI]
|
1.42071e-05
|
|
|
COH1
|
[NCBI]
|
1.42071e-05
|
|
|
NOVA2
|
[NCBI]
|
1.42071e-05
|
|
|
MTTH
|
[NCBI]
|
1.42071e-05
|
|
|
LSS
|
[NCBI]
|
1.42071e-05
|
|
|
ARNT2
|
[NCBI]
|
1.42071e-05
|
|
|
KIR2DL2
|
[NCBI]
|
1.42071e-05
|
|
|
GRK1
|
[NCBI]
|
1.42071e-05
|
|
|
BBS1
|
[NCBI]
|
1.42071e-05
|
|
|
CRMP1
|
[NCBI]
|
1.42071e-05
|
|
|
DTX1
|
[NCBI]
|
1.42071e-05
|
|
|
bsnd gene
|
[NCBI]
|
1.42071e-05
|
|
|
DLC1
|
[NCBI]
|
1.42071e-05
|
|
|
VBP1
|
[NCBI]
|
1.42071e-05
|
|
|
canavan disease
|
[NCBI]
|
1.38872e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
1.38872e-05
|
|
|
PLOSL
|
[NCBI]
|
1.38872e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
1.38872e-05
|
|
|
AAA
|
[NCBI]
|
1.38872e-05
|
|
|
KTCN1
|
[NCBI]
|
1.38872e-05
|
|
|
SMN2
|
[NCBI]
|
1.38833e-05
|
|
|
LEPR
|
[NCBI]
|
1.38215e-05
|
|
|
MMP3
|
[NCBI]
|
1.33922e-05
|
|
|
RTT
|
[NCBI]
|
1.32817e-05
|
|
|
CNTF
|
[NCBI]
|
1.32756e-05
|
|
|
LMNA
|
[NCBI]
|
1.32624e-05
|
|
|
TPM2
|
[NCBI]
|
1.32488e-05
|
|
|
SNAI1
|
[NCBI]
|
1.32488e-05
|
|
|
FBXW4
|
[NCBI]
|
1.32488e-05
|
|
|
LCP2
|
[NCBI]
|
1.32488e-05
|
|
|
CDKN2C
|
[NCBI]
|
1.32488e-05
|
|
|
AXIN1
|
[NCBI]
|
1.32488e-05
|
|
|
CHRNB1
|
[NCBI]
|
1.32488e-05
|
|
|
TTID
|
[NCBI]
|
1.32488e-05
|
|
|
NCOA4
|
[NCBI]
|
1.32488e-05
|
|
|
KCNE3
|
[NCBI]
|
1.32488e-05
|
|
|
DEK
|
[NCBI]
|
1.32488e-05
|
|
|
WNT2
|
[NCBI]
|
1.32488e-05
|
|
|
FNTA
|
[NCBI]
|
1.32488e-05
|
|
|
KIR2DL4
|
[NCBI]
|
1.32488e-05
|
|
|
KHSRP
|
[NCBI]
|
1.32488e-05
|
|
|
KCNQ3
|
[NCBI]
|
1.32488e-05
|
|
|
GPX2
|
[NCBI]
|
1.32488e-05
|
|
|
SCN4A
|
[NCBI]
|
1.31564e-05
|
|
|
TYR
|
[NCBI]
|
1.31269e-05
|
|
|
NHS
|
[NCBI]
|
1.31233e-05
|
|
|
GLC3A
|
[NCBI]
|
1.31233e-05
|
|
|
EDMD2
|
[NCBI]
|
1.31233e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
1.31233e-05
|
|
|
UCMD
|
[NCBI]
|
1.31233e-05
|
|
|
SOX9
|
[NCBI]
|
1.29269e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.27687e-05
|
|
|
ALS1
|
[NCBI]
|
1.27687e-05
|
|
|
MC1R
|
[NCBI]
|
1.26015e-05
|
|
|
PPP1R2
|
[NCBI]
|
1.24338e-05
|
|
|
COLQ
|
[NCBI]
|
1.24338e-05
|
|
|
RPL7A
|
[NCBI]
|
1.24338e-05
|
|
|
SEPN1
|
[NCBI]
|
1.24338e-05
|
|
|
IL11
|
[NCBI]
|
1.24338e-05
|
|
|
SLC7A7
|
[NCBI]
|
1.24338e-05
|
|
|
cocaine- and amphetamine-regulated transcript
|
[NCBI]
|
1.24338e-05
|
|
|
EVPL
|
[NCBI]
|
1.24338e-05
|
|
|
SLC10A2
|
[NCBI]
|
1.24338e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
1.24071e-05
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
1.24071e-05
|
|
|
MDC1A
|
[NCBI]
|
1.24071e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
1.24071e-05
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
1.24071e-05
|
|
|
ADA
|
[NCBI]
|
1.2099e-05
|
|
|
XDH
|
[NCBI]
|
1.20808e-05
|
|
|
CSNB1A
|
[NCBI]
|
1.17344e-05
|
|
|
PSNP1
|
[NCBI]
|
1.17344e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
1.17344e-05
|
|
|
CHNG2
|
[NCBI]
|
1.17344e-05
|
|
|
sudden infant death syndrome
|
[NCBI]
|
1.17344e-05
|
|
|
DRD
|
[NCBI]
|
1.17344e-05
|
|
|
USH2A
|
[NCBI]
|
1.17344e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
1.17344e-05
|
|
|
CCKBR
|
[NCBI]
|
1.17261e-05
|
|
|
ST7
|
[NCBI]
|
1.17261e-05
|
|
|
KRT12
|
[NCBI]
|
1.17261e-05
|
|
|
MLLT4
|
[NCBI]
|
1.17261e-05
|
|
|
BDKRB2
|
[NCBI]
|
1.17261e-05
|
|
|
SACS
|
[NCBI]
|
1.17261e-05
|
|
|
PVALB
|
[NCBI]
|
1.17261e-05
|
|
|
RCV1
|
[NCBI]
|
1.17261e-05
|
|
|
NEUROG3
|
[NCBI]
|
1.17261e-05
|
|
|
GPD2
|
[NCBI]
|
1.17261e-05
|
|
|
CASP10
|
[NCBI]
|
1.17261e-05
|
|
|
ARSE
|
[NCBI]
|
1.17261e-05
|
|
|
MTRR
|
[NCBI]
|
1.17261e-05
|
|
|
CHRND
|
[NCBI]
|
1.17261e-05
|
|
|
BCL10
|
[NCBI]
|
1.17261e-05
|
|
|
ACVR2
|
[NCBI]
|
1.17261e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
1.16645e-05
|
|
|
HS
|
[NCBI]
|
1.14713e-05
|
|
|
ABCC8
|
[NCBI]
|
1.13923e-05
|
|
|
LDB3
|
[NCBI]
|
1.11015e-05
|
|
|
KCNJ6
|
[NCBI]
|
1.11015e-05
|
|
|
LEFTY2
|
[NCBI]
|
1.11015e-05
|
|
|
PEX12
|
[NCBI]
|
1.11015e-05
|
|
|
CNGB3
|
[NCBI]
|
1.11015e-05
|
|
|
CTSG
|
[NCBI]
|
1.11015e-05
|
|
|
ATP8B1
|
[NCBI]
|
1.11015e-05
|
|
|
ZIC2
|
[NCBI]
|
1.11015e-05
|
|
|
LITAF
|
[NCBI]
|
1.11015e-05
|
|
|
MBD4
|
[NCBI]
|
1.11015e-05
|
|
|
EYA4
|
[NCBI]
|
1.11015e-05
|
|
|
SHC1
|
[NCBI]
|
1.11015e-05
|
|
|
GRID2
|
[NCBI]
|
1.11015e-05
|
|
|
LMAN1
|
[NCBI]
|
1.11015e-05
|
|
|
IMPDH1
|
[NCBI]
|
1.11015e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
1.11013e-05
|
|
|
FLNA
|
[NCBI]
|
1.10979e-05
|
|
|
AS
|
[NCBI]
|
1.09252e-05
|
|
|
KIT
|
[NCBI]
|
1.07408e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.05789e-05
|
|
|
CYP27A1
|
[NCBI]
|
1.05435e-05
|
|
|
COL5A2
|
[NCBI]
|
1.05435e-05
|
|
|
NPHP1
|
[NCBI]
|
1.05435e-05
|
|
|
FACL4
|
[NCBI]
|
1.05435e-05
|
|
|
ACO2
|
[NCBI]
|
1.05435e-05
|
|
|
BARD1
|
[NCBI]
|
1.05435e-05
|
|
|
GSS
|
[NCBI]
|
1.05435e-05
|
|
|
NPPB
|
[NCBI]
|
1.05435e-05
|
|
|
AAAS
|
[NCBI]
|
1.05435e-05
|
|
|
NR2E3
|
[NCBI]
|
1.05435e-05
|
|
|
MXI1
|
[NCBI]
|
1.05435e-05
|
|
|
HESX1
|
[NCBI]
|
1.05435e-05
|
|
|
TGIF
|
[NCBI]
|
1.05435e-05
|
|
|
MRXHF1
|
[NCBI]
|
1.05045e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
1.05045e-05
|
|
|
charge syndrome
|
[NCBI]
|
1.05045e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
1.05045e-05
|
|
|
SMA1
|
[NCBI]
|
1.04535e-05
|
|
|
BL
|
[NCBI]
|
1.02341e-05
|
|
|
PMD
|
[NCBI]
|
1.01668e-05
|
|
|
EIG
|
[NCBI]
|
1.01668e-05
|
|
|
MSH3
|
[NCBI]
|
1.00398e-05
|
|
|
RDH5
|
[NCBI]
|
1.00398e-05
|
|
|
POU3F4
|
[NCBI]
|
1.00398e-05
|
|
|
KIR2DL1
|
[NCBI]
|
1.00398e-05
|
|
|
HPS1
|
[NCBI]
|
1.00398e-05
|
|
|
MAP3K8
|
[NCBI]
|
1.00398e-05
|
|
|
CX3CR1
|
[NCBI]
|
1.00398e-05
|
|
|
RPL3
|
[NCBI]
|
1.00398e-05
|
|
|
PAX9
|
[NCBI]
|
1.00398e-05
|
|
|
MERTK
|
[NCBI]
|
1.00398e-05
|
|
|
IL12RB1
|
[NCBI]
|
1.00398e-05
|
|
|
ALD
|
[NCBI]
|
9.98077e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
9.9412e-06
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
9.9412e-06
|
|
|
HD
|
[NCBI]
|
9.92232e-06
|
|
|
KRAS
|
[NCBI]
|
9.75681e-06
|
|
|
KRT18
|
[NCBI]
|
9.58127e-06
|
|
|
MID1
|
[NCBI]
|
9.58127e-06
|
|
|
USP7
|
[NCBI]
|
9.58127e-06
|
|
|
FKTN
|
[NCBI]
|
9.58127e-06
|
|
|
KIR3DL1
|
[NCBI]
|
9.58127e-06
|
|
|
KRT8
|
[NCBI]
|
9.58127e-06
|
|
|
GNAQ
|
[NCBI]
|
9.58127e-06
|
|
|
OCRL
|
[NCBI]
|
9.58127e-06
|
|
|
COL6A3
|
[NCBI]
|
9.58127e-06
|
|
|
SIX3
|
[NCBI]
|
9.58127e-06
|
|
|
EMX2
|
[NCBI]
|
9.58127e-06
|
|
|
KLK1
|
[NCBI]
|
9.58127e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
9.57551e-06
|
|
|
BRCA2
|
[NCBI]
|
9.52949e-06
|
|
|
GTS
|
[NCBI]
|
9.45755e-06
|
|
|
VDR
|
[NCBI]
|
9.41945e-06
|
|
|
RCDP1
|
[NCBI]
|
9.40871e-06
|
|
|
EVC
|
[NCBI]
|
9.40871e-06
|
|
|
ELN
|
[NCBI]
|
9.16429e-06
|
|
|
DAZL
|
[NCBI]
|
9.16105e-06
|
|
|
CDX2
|
[NCBI]
|
9.16105e-06
|
|
|
DUOX2
|
[NCBI]
|
9.16105e-06
|
|
|
CA4
|
[NCBI]
|
9.16105e-06
|
|
|
MEST
|
[NCBI]
|
9.16105e-06
|
|
|
CSF2RB
|
[NCBI]
|
9.16105e-06
|
|
|
MSR1
|
[NCBI]
|
9.16105e-06
|
|
|
GSK3A
|
[NCBI]
|
9.16105e-06
|
|
|
OLR1
|
[NCBI]
|
9.16105e-06
|
|
|
MTHFD1
|
[NCBI]
|
9.16105e-06
|
|
|
CALCR
|
[NCBI]
|
9.16105e-06
|
|
|
ATXN2
|
[NCBI]
|
9.16105e-06
|
|
|
phenylketonuria
|
[NCBI]
|
8.96316e-06
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
8.90478e-06
|
|
|
PHS
|
[NCBI]
|
8.90478e-06
|
|
|
DAR
|
[NCBI]
|
8.90478e-06
|
|
|
ACP5
|
[NCBI]
|
8.78819e-06
|
|
|
EPM2A
|
[NCBI]
|
8.77362e-06
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
8.77362e-06
|
|
|
CRYGD
|
[NCBI]
|
8.77362e-06
|
|
|
RHAG
|
[NCBI]
|
8.77362e-06
|
|
|
SLC5A1
|
[NCBI]
|
8.77362e-06
|
|
|
NEFH
|
[NCBI]
|
8.77362e-06
|
|
|
CLDN1
|
[NCBI]
|
8.77362e-06
|
|
|
FOXE1
|
[NCBI]
|
8.77362e-06
|
|
|
SCN2A
|
[NCBI]
|
8.77362e-06
|
|
|
SLC27A1
|
[NCBI]
|
8.77362e-06
|
|
|
BTD
|
[NCBI]
|
8.77362e-06
|
|
|
PXE
|
[NCBI]
|
8.73886e-06
|
|
|
TFPI
|
[NCBI]
|
8.70417e-06
|
|
|
PAX3
|
[NCBI]
|
8.48464e-06
|
|
|
apert syndrome
|
[NCBI]
|
8.42738e-06
|
|
|
RP1
|
[NCBI]
|
8.42738e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
8.42738e-06
|
|
|
OTOF
|
[NCBI]
|
8.41457e-06
|
|
|
TNFRSF11A
|
[NCBI]
|
8.41457e-06
|
|
|
PDC
|
[NCBI]
|
8.41457e-06
|
|
|
PFC
|
[NCBI]
|
8.41457e-06
|
|
|
TULP1
|
[NCBI]
|
8.41457e-06
|
|
|
INVS
|
[NCBI]
|
8.41457e-06
|
|
|
CCKAR
|
[NCBI]
|
8.41457e-06
|
|
|
CRB1
|
[NCBI]
|
8.41457e-06
|
|
|
SDHB
|
[NCBI]
|
8.41457e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
8.17564e-06
|
|
|
MECP2
|
[NCBI]
|
8.14293e-06
|
|
|
COL18A1
|
[NCBI]
|
8.08038e-06
|
|
|
PANK2
|
[NCBI]
|
8.08038e-06
|
|
|
MC3R
|
[NCBI]
|
8.08038e-06
|
|
|
ZEB2
|
[NCBI]
|
8.08038e-06
|
|
|
PLA2G2A
|
[NCBI]
|
8.08038e-06
|
|
|
SLC26A2
|
[NCBI]
|
8.08038e-06
|
|
|
PCSK1
|
[NCBI]
|
8.08038e-06
|
|
|
SELE
|
[NCBI]
|
8.08038e-06
|
|
|
CYP2C9
|
[NCBI]
|
8.08038e-06
|
|
|
GJD2
|
[NCBI]
|
8.08038e-06
|
|
|
ALOX5
|
[NCBI]
|
8.08038e-06
|
|
|
GABRB3
|
[NCBI]
|
8.08038e-06
|
|
|
NCF1
|
[NCBI]
|
8.08038e-06
|
|
|
graves disease
|
[NCBI]
|
7.97466e-06
|
|
|
ARSA
|
[NCBI]
|
7.86416e-06
|
|
|
FGA
|
[NCBI]
|
7.86416e-06
|
|
|
MAN2B1
|
[NCBI]
|
7.76809e-06
|
|
|
SLC45A2
|
[NCBI]
|
7.76809e-06
|
|
|
CCR2
|
[NCBI]
|
7.76809e-06
|
|
|
CRX
|
[NCBI]
|
7.76809e-06
|
|
|
SMAD3
|
[NCBI]
|
7.76809e-06
|
|
|
MYO6
|
[NCBI]
|
7.76809e-06
|
|
|
MEF2A
|
[NCBI]
|
7.76809e-06
|
|
|
DLG4
|
[NCBI]
|
7.76809e-06
|
|
|
RNASEL
|
[NCBI]
|
7.76809e-06
|
|
|
ROR2
|
[NCBI]
|
7.76809e-06
|
|
|
SCNN1A
|
[NCBI]
|
7.76809e-06
|
|
|
TAZ
|
[NCBI]
|
7.76809e-06
|
|
|
SCNN1B
|
[NCBI]
|
7.76809e-06
|
|
|
RAD51
|
[NCBI]
|
7.76809e-06
|
|
|
C7
|
[NCBI]
|
7.76809e-06
|
|
|
BTRC
|
[NCBI]
|
7.76809e-06
|
|
|
PAX1
|
[NCBI]
|
7.76809e-06
|
|
|
GJA4
|
[NCBI]
|
7.76809e-06
|
|
|
APOA1
|
[NCBI]
|
7.6308e-06
|
|
|
FA
|
[NCBI]
|
7.56728e-06
|
|
|
LGMD2C
|
[NCBI]
|
7.545e-06
|
|
|
UGB
|
[NCBI]
|
7.51708e-06
|
|
|
EXT2
|
[NCBI]
|
7.47528e-06
|
|
|
SURF1
|
[NCBI]
|
7.47528e-06
|
|
|
ACADVL
|
[NCBI]
|
7.47528e-06
|
|
|
NEFL
|
[NCBI]
|
7.47528e-06
|
|
|
IL6ST
|
[NCBI]
|
7.47528e-06
|
|
|
GJA3
|
[NCBI]
|
7.47528e-06
|
|
|
CBP
|
[NCBI]
|
7.47528e-06
|
|
|
BHMT
|
[NCBI]
|
7.47528e-06
|
|
|
GDI1
|
[NCBI]
|
7.47528e-06
|
|
|
SPG7
|
[NCBI]
|
7.47528e-06
|
|
|
ACTA1
|
[NCBI]
|
7.47528e-06
|
|
|
IL2
|
[NCBI]
|
7.43591e-06
|
|
|
IDUA
|
[NCBI]
|
7.29531e-06
|
|
|
PER2
|
[NCBI]
|
7.19989e-06
|
|
|
PCDH15
|
[NCBI]
|
7.19989e-06
|
|
|
ADRB3
|
[NCBI]
|
7.19989e-06
|
|
|
SGCE
|
[NCBI]
|
7.19989e-06
|
|
|
KCNJ2
|
[NCBI]
|
7.19989e-06
|
|
|
COL11A2
|
[NCBI]
|
7.19989e-06
|
|
|
PCCB
|
[NCBI]
|
7.19989e-06
|
|
|
FUT2
|
[NCBI]
|
7.19989e-06
|
|
|
MTR
|
[NCBI]
|
7.18717e-06
|
|
|
gastric cancer
|
[NCBI]
|
7.13689e-06
|
|
|
FCHL
|
[NCBI]
|
7.13689e-06
|
|
|
RAG2
|
[NCBI]
|
6.94018e-06
|
|
|
NEU1
|
[NCBI]
|
6.94018e-06
|
|
|
CHRNA4
|
[NCBI]
|
6.94018e-06
|
|
|
AMELX
|
[NCBI]
|
6.94018e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
6.94018e-06
|
|
|
ZS
|
[NCBI]
|
6.84463e-06
|
|
|
APS1
|
[NCBI]
|
6.84463e-06
|
|
|
PARK2
|
[NCBI]
|
6.74898e-06
|
|
|
PGL1
|
[NCBI]
|
6.74898e-06
|
|
|
NRL
|
[NCBI]
|
6.69465e-06
|
|
|
HAMP
|
[NCBI]
|
6.69465e-06
|
|
|
HR
|
[NCBI]
|
6.69465e-06
|
|
|
ORM1
|
[NCBI]
|
6.69465e-06
|
|
|
PI3
|
[NCBI]
|
6.69465e-06
|
|
|
CLN3
|
[NCBI]
|
6.69465e-06
|
|
|
CTSD
|
[NCBI]
|
6.69465e-06
|
|
|
SSTR2
|
[NCBI]
|
6.69465e-06
|
|
|
PEX7
|
[NCBI]
|
6.69465e-06
|
|
|
TBX5
|
[NCBI]
|
6.69465e-06
|
|
|
CYP1A1
|
[NCBI]
|
6.6841e-06
|
|
|
POMC
|
[NCBI]
|
6.55952e-06
|
|
|
SLC6A3
|
[NCBI]
|
6.49223e-06
|
|
|
PDGFRA
|
[NCBI]
|
6.46201e-06
|
|
|
IL1RN
|
[NCBI]
|
6.46201e-06
|
|
|
PLOD1
|
[NCBI]
|
6.46201e-06
|
|
|
MAP3K7
|
[NCBI]
|
6.46201e-06
|
|
|
F12
|
[NCBI]
|
6.46201e-06
|
|
|
PDGFRB
|
[NCBI]
|
6.46201e-06
|
|
|
ATP2A2
|
[NCBI]
|
6.46201e-06
|
|
|
myoclonic dystonia
|
[NCBI]
|
6.38007e-06
|
|
|
AACT
|
[NCBI]
|
6.24114e-06
|
|
|
PAX8
|
[NCBI]
|
6.24114e-06
|
|
|
CTSB
|
[NCBI]
|
6.24114e-06
|
|
|
SDHD
|
[NCBI]
|
6.24114e-06
|
|
|
NR3C2
|
[NCBI]
|
6.24114e-06
|
|
|
GJB3
|
[NCBI]
|
6.24114e-06
|
|
|
RPE65
|
[NCBI]
|
6.24114e-06
|
|
|
NRTN
|
[NCBI]
|
6.24114e-06
|
|
|
WT1
|
[NCBI]
|
6.21593e-06
|
|
|
COL2A1
|
[NCBI]
|
6.10582e-06
|
|
|
MSX1
|
[NCBI]
|
6.03106e-06
|
|
|
CDH23
|
[NCBI]
|
6.03106e-06
|
|
|
CRYAA
|
[NCBI]
|
6.03106e-06
|
|
|
CYP11B1
|
[NCBI]
|
6.03106e-06
|
|
|
LHB
|
[NCBI]
|
6.03106e-06
|
|
|
HIGM1
|
[NCBI]
|
6.02902e-06
|
|
|
meningioma, familial
|
[NCBI]
|
6.02902e-06
|
|
|
campomelic dysplasia
|
[NCBI]
|
6.02902e-06
|
|
|
HNF1A
|
[NCBI]
|
6.01643e-06
|
|
|
homocystinuria
|
[NCBI]
|
5.84165e-06
|
|
|
KLF6
|
[NCBI]
|
5.8309e-06
|
|
|
MTCO3
|
[NCBI]
|
5.8309e-06
|
|
|
LRP5
|
[NCBI]
|
5.8309e-06
|
|
|
EGR2
|
[NCBI]
|
5.8309e-06
|
|
|
NKX2E
|
[NCBI]
|
5.8309e-06
|
|
|
SLC12A3
|
[NCBI]
|
5.8309e-06
|
|
|
TNFSF6
|
[NCBI]
|
5.70816e-06
|
|
|
malaria, susceptibility to
|
[NCBI]
|
5.69482e-06
|
|
|
CMTX1
|
[NCBI]
|
5.69482e-06
|
|
|
SMA3
|
[NCBI]
|
5.69482e-06
|
|
|
WFS1
|
[NCBI]
|
5.69482e-06
|
|
|
CLN3
|
[NCBI]
|
5.69482e-06
|
|
|
LYZ
|
[NCBI]
|
5.6399e-06
|
|
|
GALC
|
[NCBI]
|
5.6399e-06
|
|
|
CDKN1C
|
[NCBI]
|
5.6399e-06
|
|
|
PMS2
|
[NCBI]
|
5.6399e-06
|
|
|
SCN1A
|
[NCBI]
|
5.6399e-06
|
|
|
pta deficiency
|
[NCBI]
|
5.6399e-06
|
|
|
CRC
|
[NCBI]
|
5.59313e-06
|
|
|
HFE
|
[NCBI]
|
5.58687e-06
|
|
|
CHM
|
[NCBI]
|
5.45739e-06
|
|
|
CRYAB
|
[NCBI]
|
5.45739e-06
|
|
|
COL4A3
|
[NCBI]
|
5.45739e-06
|
|
|
IL4R
|
[NCBI]
|
5.45739e-06
|
|
|
AIRE
|
[NCBI]
|
5.42684e-06
|
|
|
LFS1
|
[NCBI]
|
5.37652e-06
|
|
|
COH1
|
[NCBI]
|
5.37652e-06
|
|
|
neuraminidase deficiency
|
[NCBI]
|
5.37652e-06
|
|
|
lactase persistence
|
[NCBI]
|
5.37652e-06
|
|
|
ITGA2B
|
[NCBI]
|
5.28275e-06
|
|
|
GAS
|
[NCBI]
|
5.28275e-06
|
|
|
GPX1
|
[NCBI]
|
5.28275e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
5.26364e-06
|
|
|
SRY
|
[NCBI]
|
5.19216e-06
|
|
|
LFNG
|
[NCBI]
|
5.11544e-06
|
|
|
IPF1
|
[NCBI]
|
5.11544e-06
|
|
|
NOG
|
[NCBI]
|
5.11544e-06
|
|
|
C1NH
|
[NCBI]
|
5.11544e-06
|
|
|
SPTB
|
[NCBI]
|
5.11544e-06
|
|
|
APEX
|
[NCBI]
|
5.11544e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
5.07328e-06
|
|
|
GNAS
|
[NCBI]
|
5.04124e-06
|
|
|
PGR
|
[NCBI]
|
5.03273e-06
|
|
|
GUSB
|
[NCBI]
|
4.96738e-06
|
|
|
TTN
|
[NCBI]
|
4.95497e-06
|
|
|
RYR2
|
[NCBI]
|
4.95497e-06
|
|
|
GP1BA
|
[NCBI]
|
4.95497e-06
|
|
|
TP73L
|
[NCBI]
|
4.95497e-06
|
|
|
AHR
|
[NCBI]
|
4.87254e-06
|
|
|
ACVRL1
|
[NCBI]
|
4.8009e-06
|
|
|
HGFAC
|
[NCBI]
|
4.8009e-06
|
|
|
IL1B
|
[NCBI]
|
4.8009e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
4.8009e-06
|
|
|
APOH
|
[NCBI]
|
4.8009e-06
|
|
|
ATXN1
|
[NCBI]
|
4.8009e-06
|
|
|
TGFBR2
|
[NCBI]
|
4.8009e-06
|
|
|
MSH6
|
[NCBI]
|
4.8009e-06
|
|
|
DPYD
|
[NCBI]
|
4.8009e-06
|
|
|
IRS2
|
[NCBI]
|
4.8009e-06
|
|
|
TWIST1
|
[NCBI]
|
4.8009e-06
|
|
|
CAV3
|
[NCBI]
|
4.8009e-06
|
|
|
SPP1
|
[NCBI]
|
4.79941e-06
|
|
|
TRPS2
|
[NCBI]
|
4.7843e-06
|
|
|
BTHS
|
[NCBI]
|
4.7843e-06
|
|
|
FTL
|
[NCBI]
|
4.65284e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
4.65284e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
4.65284e-06
|
|
|
ALDH3A2
|
[NCBI]
|
4.65284e-06
|
|
|
ALPL
|
[NCBI]
|
4.65284e-06
|
|
|
MTRNR1
|
[NCBI]
|
4.65284e-06
|
|
|
ABCC1
|
[NCBI]
|
4.63853e-06
|
|
|
ENPP1
|
[NCBI]
|
4.51041e-06
|
|
|
POAG
|
[NCBI]
|
4.50884e-06
|
|
|
SMEI
|
[NCBI]
|
4.50884e-06
|
|
|
FOP
|
[NCBI]
|
4.50884e-06
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
4.50884e-06
|
|
|
CFI
|
[NCBI]
|
4.37328e-06
|
|
|
IL5
|
[NCBI]
|
4.37328e-06
|
|
|
POU1F1
|
[NCBI]
|
4.37328e-06
|
|
|
FMO3
|
[NCBI]
|
4.24116e-06
|
|
|
PEPD
|
[NCBI]
|
4.24116e-06
|
|
|
NBS1
|
[NCBI]
|
4.24116e-06
|
|
|
CBD
|
[NCBI]
|
4.24116e-06
|
|
|
PPARG
|
[NCBI]
|
4.15703e-06
|
|
|
FHIT
|
[NCBI]
|
4.11376e-06
|
|
|
IL13
|
[NCBI]
|
4.11376e-06
|
|
|
GHRL
|
[NCBI]
|
4.11376e-06
|
|
|
CMH
|
[NCBI]
|
4.11103e-06
|
|
|
CHS
|
[NCBI]
|
4.07646e-06
|
|
|
HAE
|
[NCBI]
|
3.99585e-06
|
|
|
ABCC6
|
[NCBI]
|
3.99083e-06
|
|
|
GATA1
|
[NCBI]
|
3.99083e-06
|
|
|
UCP2
|
[NCBI]
|
3.91513e-06
|
|
|
TPMT
|
[NCBI]
|
3.91513e-06
|
|
|
XPA
|
[NCBI]
|
3.87214e-06
|
|
|
ASPA
|
[NCBI]
|
3.87214e-06
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
3.87214e-06
|
|
|
GK
|
[NCBI]
|
3.87214e-06
|
|
|
RAG1
|
[NCBI]
|
3.87214e-06
|
|
|
SLC26A4
|
[NCBI]
|
3.87214e-06
|
|
|
FGG
|
[NCBI]
|
3.87214e-06
|
|
|
RECQL2
|
[NCBI]
|
3.75746e-06
|
|
|
MICA
|
[NCBI]
|
3.75746e-06
|
|
|
CHEK2
|
[NCBI]
|
3.75746e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
3.7571e-06
|
|
|
JPS
|
[NCBI]
|
3.7571e-06
|
|
|
XPA
|
[NCBI]
|
3.7571e-06
|
|
|
IP
|
[NCBI]
|
3.67534e-06
|
|
|
SLC1A2
|
[NCBI]
|
3.64659e-06
|
|
|
NR0B1
|
[NCBI]
|
3.64659e-06
|
|
|
DSG1
|
[NCBI]
|
3.64659e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
3.53935e-06
|
|
|
CUTL1
|
[NCBI]
|
3.53935e-06
|
|
|
fucosidosis
|
[NCBI]
|
3.53935e-06
|
|
|
PDHA1
|
[NCBI]
|
3.43557e-06
|
|
|
SLC16A1
|
[NCBI]
|
3.43557e-06
|
|
|
TYMS
|
[NCBI]
|
3.38659e-06
|
|
|
SCS
|
[NCBI]
|
3.31241e-06
|
|
|
SCIDX1
|
[NCBI]
|
3.31241e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
3.30852e-06
|
|
|
HEXB
|
[NCBI]
|
3.23775e-06
|
|
|
BRAF
|
[NCBI]
|
3.23775e-06
|
|
|
AMACR
|
[NCBI]
|
3.23775e-06
|
|
|
ACH
|
[NCBI]
|
3.14411e-06
|
|
|
ENG
|
[NCBI]
|
3.14341e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
3.05195e-06
|
|
|
RUNX1
|
[NCBI]
|
3.05195e-06
|
|
|
TCRA
|
[NCBI]
|
3.05195e-06
|
|
|
GIP
|
[NCBI]
|
3.03155e-06
|
|
|
MTATP6
|
[NCBI]
|
2.96325e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
2.90695e-06
|
|
|
ABCA1
|
[NCBI]
|
2.87718e-06
|
|
|
CREBBP
|
[NCBI]
|
2.87718e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
2.87718e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
2.72028e-06
|
|
|
NTRK1
|
[NCBI]
|
2.71253e-06
|
|
|
MSTN
|
[NCBI]
|
2.71253e-06
|
|
|
MTAP
|
[NCBI]
|
2.63376e-06
|
|
|
SH2D1A
|
[NCBI]
|
2.55722e-06
|
|
|
HNPP
|
[NCBI]
|
2.5412e-06
|
|
|
GJA1
|
[NCBI]
|
2.53821e-06
|
|
|
CYP2D6
|
[NCBI]
|
2.48285e-06
|
|
|
F13A1
|
[NCBI]
|
2.48285e-06
|
|
|
GALT
|
[NCBI]
|
2.41056e-06
|
|
|
RLBP1
|
[NCBI]
|
2.41056e-06
|
|
|
AGT
|
[NCBI]
|
2.41056e-06
|
|
|
FCMD
|
[NCBI]
|
2.37064e-06
|
|
|
ABL1
|
[NCBI]
|
2.34027e-06
|
|
|
PTEN
|
[NCBI]
|
2.33697e-06
|
|
|
PMCH
|
[NCBI]
|
2.31121e-06
|
|
|
MSH2
|
[NCBI]
|
2.27191e-06
|
|
|
SLC18A2
|
[NCBI]
|
2.27191e-06
|
|
|
INSL3
|
[NCBI]
|
2.27191e-06
|
|
|
SLC6A4
|
[NCBI]
|
2.25038e-06
|
|
|
TLR4
|
[NCBI]
|
2.21503e-06
|
|
|
WS1
|
[NCBI]
|
2.20827e-06
|
|
|
PGM1
|
[NCBI]
|
2.20542e-06
|
|
|
PARG
|
[NCBI]
|
2.20542e-06
|
|
|
ALB
|
[NCBI]
|
2.18282e-06
|
|
|
DCC
|
[NCBI]
|
2.14072e-06
|
|
|
MCP
|
[NCBI]
|
2.11517e-06
|
|
|
LRP1
|
[NCBI]
|
2.11031e-06
|
|
|
ARPKD
|
[NCBI]
|
2.05375e-06
|
|
|
IGF1
|
[NCBI]
|
1.95685e-06
|
|
|
WT1
|
[NCBI]
|
1.89877e-06
|
|
|
GSC
|
[NCBI]
|
1.89877e-06
|
|
|
HNF4A
|
[NCBI]
|
1.89877e-06
|
|
|
LPL
|
[NCBI]
|
1.84585e-06
|
|
|
ITGB3
|
[NCBI]
|
1.84222e-06
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
1.84222e-06
|
|
|
hemophilia a
|
[NCBI]
|
1.75015e-06
|
|
|
IRS1
|
[NCBI]
|
1.7335e-06
|
|
|
JAK3
|
[NCBI]
|
1.68125e-06
|
|
|
SLS
|
[NCBI]
|
1.63444e-06
|
|
|
TNFSF10
|
[NCBI]
|
1.63303e-06
|
|
|
TGFB1
|
[NCBI]
|
1.63034e-06
|
|
|
LAM
|
[NCBI]
|
1.54969e-06
|
|
|
PCD
|
[NCBI]
|
1.54969e-06
|
|
|
NR5A1
|
[NCBI]
|
1.53239e-06
|
|
|
DSPP
|
[NCBI]
|
1.48529e-06
|
|
|
NR1I2
|
[NCBI]
|
1.45311e-06
|
|
|
ANG
|
[NCBI]
|
1.43938e-06
|
|
|
CCR5
|
[NCBI]
|
1.43938e-06
|
|
|
ARMD1
|
[NCBI]
|
1.3891e-06
|
|
|
COMT
|
[NCBI]
|
1.37656e-06
|
|
|
HBB
|
[NCBI]
|
1.35731e-06
|
|
|
NR0B2
|
[NCBI]
|
1.30852e-06
|
|
|
VCP
|
[NCBI]
|
1.30852e-06
|
|
|
PARK2
|
[NCBI]
|
1.18731e-06
|
|
|
RDT
|
[NCBI]
|
1.16889e-06
|
|
|
GHR
|
[NCBI]
|
1.14703e-06
|
|
|
IAPP
|
[NCBI]
|
1.13074e-06
|
|
|
FGF8
|
[NCBI]
|
1.1115e-06
|
|
|
MTTL1
|
[NCBI]
|
1.07503e-06
|
|
|
TSHR
|
[NCBI]
|
1.07503e-06
|
|
|
EPOR
|
[NCBI]
|
1.04735e-06
|
|
|
SNCA
|
[NCBI]
|
1.03947e-06
|
|
|
ARNT
|
[NCBI]
|
1.0048e-06
|
|
|
DCK
|
[NCBI]
|
9.22943e-07
|
|
|
CHH
|
[NCBI]
|
8.82056e-07
|
|
|
gaucher disease, type i
|
[NCBI]
|
8.82056e-07
|
|
|
ASS
|
[NCBI]
|
8.74685e-07
|
|
|
AQP1
|
[NCBI]
|
8.74685e-07
|
|
|
PLN
|
[NCBI]
|
8.44192e-07
|
|
|
LCT
|
[NCBI]
|
8.14476e-07
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
7.97286e-07
|
|
|
GBA
|
[NCBI]
|
7.2982e-07
|
|
|
LPI
|
[NCBI]
|
7.1765e-07
|
|
|
SHH
|
[NCBI]
|
6.87566e-07
|
|
|
CPE
|
[NCBI]
|
5.56495e-07
|
|
|
PLG
|
[NCBI]
|
5.38515e-07
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
5.07973e-07
|
|
|
PTGS2
|
[NCBI]
|
4.91681e-07
|
|
|
TLR2
|
[NCBI]
|
4.89656e-07
|
|
|
PRLR
|
[NCBI]
|
4.71247e-07
|
|
|
GH1
|
[NCBI]
|
4.71247e-07
|
|
|
hypertension, essential
|
[NCBI]
|
4.47337e-07
|
|
|
SCD
|
[NCBI]
|
4.32068e-07
|
|
|
JAK2
|
[NCBI]
|
4.1978e-07
|
|
|
FMR1
|
[NCBI]
|
4.08546e-07
|
|
|
PRNP
|
[NCBI]
|
3.23095e-07
|
|
|
APOB
|
[NCBI]
|
3.00499e-07
|
|
|
PC
|
[NCBI]
|
2.96365e-07
|
|
|
alopecia, androgenetic
|
[NCBI]
|
2.91335e-07
|
|
|
MAPK1
|
[NCBI]
|
2.81611e-07
|
|
|
AKR1B1
|
[NCBI]
|
2.77041e-07
|
|
|
lynch syndrome i
|
[NCBI]
|
2.47561e-07
|
|
|
SCA2
|
[NCBI]
|
2.47561e-07
|
|
|
DMD
|
[NCBI]
|
2.45935e-07
|
|
|
DBA
|
[NCBI]
|
2.01616e-07
|
|
|
BMP4
|
[NCBI]
|
1.90834e-07
|
|
|
ESR1
|
[NCBI]
|
1.90834e-07
|
|
|
BWS
|
[NCBI]
|
1.88321e-07
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.6986e-07
|
|
|
NPM1
|
[NCBI]
|
1.68693e-07
|
|
|
LPO
|
[NCBI]
|
1.68693e-07
|
|
|
krabbe disease
|
[NCBI]
|
1.44218e-07
|
|
|
SCA1
|
[NCBI]
|
1.44218e-07
|
|
|
OXT
|
[NCBI]
|
1.39954e-07
|
|
|
MAPT
|
[NCBI]
|
1.29123e-07
|
|
|
TPO
|
[NCBI]
|
1.21915e-07
|
|
|
CCND1
|
[NCBI]
|
1.20175e-07
|
|
|
IHH
|
[NCBI]
|
1.12594e-07
|
|
|
MITF
|
[NCBI]
|
1.03373e-07
|
|
|
WHS
|
[NCBI]
|
9.58094e-08
|
|
|
AMH
|
[NCBI]
|
9.465e-08
|
|
|
RASA1
|
[NCBI]
|
7.70759e-08
|
|
|
DNMT1
|
[NCBI]
|
5.60595e-08
|
|
|
LCAT
|
[NCBI]
|
3.3338e-08
|
|
|
PI
|
[NCBI]
|
3.04905e-08
|
|
|
SLOS
|
[NCBI]
|
2.65623e-08
|
|
|
WBS
|
[NCBI]
|
2.65623e-08
|
|
|
JMML
|
[NCBI]
|
1.80983e-08
|
|
|
GDNF
|
[NCBI]
|
9.81914e-09
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
8.57863e-09
|
|
|
ACADM
|
[NCBI]
|
8.49743e-09
|
|
|
AGER
|
[NCBI]
|
6.9514e-09
|
|
|
GC
|
[NCBI]
|
5.19052e-09
|
|
|
CFTR
|
[NCBI]
|
5.06484e-09
|
|
|
VASP
|
[NCBI]
|
2.6044e-10
|
|
|
BCHE
|
[NCBI]
|
2.2545e-10
|
|
|
CVID
|
[NCBI]
|
9.33302e-11
|
|